pubmed-article:16455781 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C1414805 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0851285 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0179400 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
pubmed-article:16455781 | lifeskim:mentions | umls-concept:C0332291 | lld:lifeskim |
pubmed-article:16455781 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16455781 | pubmed:dateCreated | 2006-4-17 | lld:pubmed |
pubmed-article:16455781 | pubmed:abstractText | The expression of IGF-binding protein-1 (IGFBP-1) is induced in rat liver by dexamethasone and glucagon and is completely inhibited by 100 nM insulin. Various studies have implicated phosphatidylinositol 3-kinase, protein kinase B (Akt), phosphorylation of the transcription factors forkhead in rhabdomyosarcoma 1 (Foxo1)/Foxo3, and the mammalian target of rapamycin (mTOR) in insulin's effect. In this study we examined insulin regulation of IGFBP-1 in both subconfluent and confluent hepatocytes. In subconfluent hepatocytes, insulin inhibition of IGFBP-1 mRNA levels was blocked by inhibiting PI3 kinase activation, and there was a corresponding inhibition of Foxo1/Foxo3 phosphorylation. In these same cells, inhibition of the insulin effect by rapamycin occurred in the presence of insulin-induced Foxo1/Foxo3 phosphorylation. In confluent hepatocytes, insulin could not activate the phosphatidylinositol 3-kinase (PI3 kinase)-Akt-Foxo1/Foxo3 pathway, but still inhibited IGFBP-1 gene expression in an mTOR-dependent manner. In subconfluent hepatocytes, the serine/threonine phosphatase inhibitor okadaic acid (100 nM) partially inhibited IGFBP-1 gene expression by 40%, but did not produce phosphorylation of either Akt or Foxo proteins. In contrast, 1 nm insulin inhibited the IGFBP-1 mRNA level by 40% and correspondingly activated Akt and Foxo1/Foxo3 phosphorylation to a level comparable to that observed with 100 nM insulin. These results suggest a potential role for a serine/threonine phosphatase(s) in the regulation of IGFBP-1 gene transcription, which is not downstream of mTOR and is independent of Akt. In conclusion, we have found that in rat liver, insulin inhibition of IGFBP-1 mRNA levels can occur in the absence of the phosphorylation of Foxo1/Foxo3, whereas activation of the mTOR pathway is both necessary and sufficient. | lld:pubmed |
pubmed-article:16455781 | pubmed:language | eng | lld:pubmed |
pubmed-article:16455781 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16455781 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16455781 | pubmed:month | May | lld:pubmed |
pubmed-article:16455781 | pubmed:issn | 0013-7227 | lld:pubmed |
pubmed-article:16455781 | pubmed:author | pubmed-author:MounierCather... | lld:pubmed |
pubmed-article:16455781 | pubmed:author | pubmed-author:DumasVictorV | lld:pubmed |
pubmed-article:16455781 | pubmed:author | pubmed-author:PosnerBarry... | lld:pubmed |
pubmed-article:16455781 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16455781 | pubmed:volume | 147 | lld:pubmed |
pubmed-article:16455781 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16455781 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16455781 | pubmed:pagination | 2383-91 | lld:pubmed |
pubmed-article:16455781 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:meshHeading | pubmed-meshheading:16455781... | lld:pubmed |
pubmed-article:16455781 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16455781 | pubmed:articleTitle | Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins. | lld:pubmed |
pubmed-article:16455781 | pubmed:affiliation | Polypeptide Hormone Laboratory, Faculty of Medicine, McGill University, Montréal, Quebéc, Canada. | lld:pubmed |
pubmed-article:16455781 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16455781 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:25685 | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
entrez-gene:56718 | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
entrez-gene:84482 | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
entrez-gene:294515 | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16455781 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16455781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16455781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16455781 | lld:pubmed |